ArticleCell reports2025
Cerebellar contributions to tau-mediated cognitive and behavioral dysfunction.
Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Dementia is characterized by loss of cognitive function, social deficits, and emotional impairment and is prevalent in tau-mediated disorders. However, the mechanisms underlying this cognitive and behavioral dysfunction remain uncertain, as phenotypes do not necessarily correlate well with the presence of tau pathology. Here, we identify critical roles for the cerebellum in regulating cognition and behavior in a tauopathy mouse model. We find that social and fear memory deficits emerge much later than tau pathology and that cerebellar Purkinje cell (PC) dysfunction coincides with the onset of memory phenotypes in P301S tau mutant mice. Similarly, a chemogenetic reduction of PC excitability in control mice results in social memory deficits. We further demonstrate that a chemogenetic increase in PC excitability improves cognitive and behavioral dysfunction in P301S mutants. Together, these findings support critical roles for the cerebellum in regulating tauopathy-relevant cognitive and behavioral deficits while also informing potential therapeutic avenues for these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.